Avascular Necrosis of Femoral Head

Courtesy: Ramesh Sen, Fortis Hospital, Mohali

 

 

Avascular Necrosis of the Femoral Head: Diagnosis, Progression, and Treatment Strategies

Key Points

1. Overview of Avascular Necrosis

• Avascular necrosis is a condition caused by reduced blood supply to the femoral head.
• This leads to bone death and eventual collapse of the joint surface.
• The disease may progress gradually and symptoms may appear late.

2. Causes and Risk Factors

• Common causes include:
  • Long-term steroid use
  • Excessive alcohol intake
  • Sickle cell disease
• In some regions, nutritional and metabolic factors may also contribute.
• Steroid dosage is strongly associated with increased risk.

3. Pathology

• In most cases, the condition is non-inflammatory.
• In specific conditions such as sickle cell disease, inflammatory changes may be present.
• The disease ultimately results in structural failure of the femoral head.

4. Clinical Presentation

• Pain is a common symptom but may appear late.
• Some patients may remain asymptomatic for several years despite disease progression.
• Physical examination may reveal limited hip movement and discomfort.

5. Imaging and Diagnosis

• X-rays:
  • May be normal in early stages.
  • Used for staging disease progression.
• Magnetic Resonance Imaging:
  • Most sensitive tool for early detection.
  • Shows characteristic signal changes in the femoral head.
  • Helps determine the extent and location of involvement.
• Additional Imaging:
  • Advanced imaging methods may assist in selected cases.
  • Used for monitoring response to treatment.

6. Disease Progression

• The size and location of the lesion influence prognosis.
• Larger lesions are more likely to progress.
• Involvement of weight-bearing areas carries a poorer outcome.
• The condition may remain stable for years before becoming symptomatic.

7. Natural History

• Small lesions may remain stable over time.
• Larger lesions tend to progress or remain unchanged rather than improve.
• Joint collapse marks the transition to advanced disease.

8. Non-Surgical Management

• Restriction of weight-bearing alone does not significantly alter disease progression.
• Various medical therapies have been explored, including:
  • Lipid-lowering agents
  • Hyperbaric oxygen therapy
  • Shockwave therapy
  • Electromagnetic stimulation
  • Anticoagulants in selected cases
• Bisphosphonates may help slow bone resorption, though evidence is variable.

9. Surgical Treatment Options

• Core Decompression:
  • Standard early intervention.
  • Reduces pressure within the bone and improves blood flow.
  • More effective in early stages.
• Bone Grafting:
  • Provides structural support and promotes healing.
  • Can be combined with other techniques.
• Cell-Based Therapies:
  • Bone marrow-derived cells may enhance healing.
  • Increasing evidence supports their use in early disease.
• Vascularized Grafts:
  • Restore blood supply to the affected area.
  • Useful in selected patients.
• Osteotomy:
  • Alters load distribution on the femoral head.
  • Technically demanding and less commonly performed.

10. Advanced Disease Management

• Once collapse occurs, joint preservation becomes difficult.
• Total hip replacement is the most effective treatment in advanced stages.
• Previous surgeries may influence outcomes of joint replacement.

11. Treatment Approach by Stage

• Early stage:
  • Core decompression, with or without adjunct therapies.
• Intermediate stage:
  • Bone grafting or cell-based treatments.
• Advanced stage:
  • Joint replacement surgery.

12. Key Takeaways

• Early diagnosis is critical to preserve the hip joint.
• Magnetic resonance imaging is essential for detecting early disease.
• Lesion size and location determine prognosis.
• Treatment should be stage-based and individualized.
• Joint replacement remains the definitive option in advanced cases.